NEWS

Sansure Immunological Technology Platform adopts advanced nanoparticle technology, protein labelling and modification technology, using high quality coloured latex and colloidal gold as tracers, and has developed a series of easy-to-use, highly sensitive and rapid detection products, covering SARS-CoV-2 antigen, SARS-CoV-2/InFluA/InFluB antigen, SARS-CoV-2 neutralizing antibody and other SARS-CoV-2 immunological reagents, to meet the needs of different scenarios such as home self-test, POCT and laboratory testing.

Meet Sansure in Mexico!

Sansure will be attending the “2021 Expo Med” . The international exhibition will be held from September 29th – October 1st in Mexico City (https://www.expomed.com.mx/en/home.html). If you would like to get more information about “Sansure Comprehensive COVID-19 diagnostic solutions”, “Sansure overall molecular diagnostic solutions” ,” and newly released molecular POCT devices, You are warmly welcome to visit our booth #3229 […]

LEARN MORE
Innovation Makes a Difference! Sansure Biotech Listed on the Top 100 Pharmaceutical Enterprises in China

On August 1st, the much-anticipated Top 100 Pharmaceutical Enterprises in China for 2020 was officially released at the 38th China Pharmaceutical Industry Information Annual Conference 2021, which was organized by the China National Pharmaceutical Industry Information Center. Sinopharm, Yangtze River Pharmaceutical Group and Guangzhou Pharmaceutical Holdings were ranked top three while Sansure Biotech, ranked 59th, is the only biomedical company […]

LEARN MORE
Sansure Statement on the effectiveness of nucleic acid test kits for the SARS-CoV-2 variants detection

Sansure Statement on the effectiveness of nucleic acid test kits for the SARS-CoV-2 variants detection

LEARN MORE
The Detection Kit for 5 Mutations of SARS-CoV-2 of Sansure Biotech obtained the CE certification

Recently, the Detection Kit for 5 Mutations of SARS-CoV-2 (PCR-Fluorescence Probing) developed by Sansure Biotech have obtained the European Union CE certification. This is another COVID-19 mutations diagnostic product which obtained the EU CE certification after the mutations diagnostic kit for the identification of B.1.1.7 major mutation sites N501Y and HV69-70 del obtained the CE certification. This product can simultaneously […]

LEARN MORE
South African Ambassador to China SC Cwele visited Sansure Biotech

On the afternoon of May 21, Mr. SC Cwele, the Ambassador of the Republic of South Africa to China, and Yusuf Timol, the ambassador of the Republic of South Africa, visited Sansure Biotech along with the leaders of the Changsha High-tech Zone Management Committee and Mr. Lizhong Dai, Chairman of the Board of Sansure Biotech. The two parties conducted an […]

LEARN MORE